Standard InChI: InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27) (Source: PubChem)
IUPAC Name: N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine (Source: PubChem)
PubChem CID: 3081361 (Source: PubChem)
SMILES String: CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC (Source: PubChem)
IUPAC Name: N-(4-bromo-2-fluorophenyl)-6-methoxy-7-(piperidin-4-ylmethoxy)quinazolin-4-amine (Source: Human Metabolome Database)
SMILES String: COC1=C(OCC2CCNCC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1 (Source: Human Metabolome Database)
Standard InChI: InChI=1S/C21H22BrFN4O2/c1-28-19-9-15-18(10-20(19)29-11-13-4-6-24-7-5-13)25-12-26-21(15)27-17-3-2-14(22)8-16(17)23/h2-3,8-10,12-13,24H,4-7,11H2,1H3,(H,25,26,27) (Source: Human Metabolome Database)
Standard InChIKey: HTCPERSEGREUFC-UHFFFAOYSA-N (Source: Human Metabolome Database)
CAS Registry Number: 443913-73-3 (Source: Wikidata)
IUPAC Name: N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine (Source: USEPA CompTox Dashboard)
Brand Name: Caprelsa (Source: USEPA CompTox Dashboard)
Brand Name: Caprelsa (Source: Human Metabolome Database)
Brand Name: Caprelsa (Source: DrugBank)
Standard InChI: InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27) (Source: Wikidata)
Standard InChIKey: UHTHHESEBZOYNR-UHFFFAOYSA-N (Source: Wikidata)
Standard InChIKey: UHTHHESEBZOYNR-UHFFFAOYSA-N (Source: Wikidata)
Standard InChIKey: UHTHHESEBZOYNR-UHFFFAOYSA-N (Source: Probes and Drugs)
Standard InChIKey: UHTHHESEBZOYNR-UHFFFAOYSA-N (Source: USEPA CompTox Dashboard)
CAS Registry Number: 443913-73-3 (Source: PubChem)
Connectivity SMILES string: CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC (Source: PubChem)
Standard InChIKey: UHTHHESEBZOYNR-UHFFFAOYSA-N (Source: PubChem)
ChEBI ID: CHEBI:49960 (Source: PubChem)
ChEMBL ID: CHEMBL24828 (Source: PubChem)
CompTox Dashboard Compound ID: DTXCID9026681 (Source: PubChem)
CompTox Dashboard Substance ID: DTXSID1046681 (Source: PubChem)
Wikidata ID: Q7914515 (Source: PubChem)
WHO ATC Classification Drug Code: L01EX04 (Source: ChEMBL)
WHO ATC Classification Drug Name: Vandetanib (Source: ChEMBL)
British Approved Name: Vandetanib (Source: ChEMBL)
British National Formulary: Vandetanib (Source: ChEMBL)
Connectivity SMILES string: COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1 (Source: ChEMBL)
European Medicines Agency Name: Vandetanib (Source: ChEMBL)
International Nonproprietary Name: Vandetanib (Source: ChEMBL)
Japanese Adopted Name: Vandetanib (Source: ChEMBL)
Merck Index Name: Vandetanib (Source: ChEMBL)
Preferred Name: VANDETANIB (Source: ChEMBL)
Standard InChI: InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27) (Source: ChEMBL)
Standard InChIKey: UHTHHESEBZOYNR-UHFFFAOYSA-N (Source: ChEMBL)
US Adopted Name: Vandetanib (Source: ChEMBL)